
Chinese General Practice ›› 2022, Vol. 25 ›› Issue (27): 3384-3389.DOI: 10.12114/j.issn.1007-9572.2022.0269
• Article • Previous Articles Next Articles
Received:2022-03-05
Revised:2022-05-10
Published:2022-09-20
Online:2022-06-23
Contact:
Zhen YU
About author:
通讯作者:
玉珍
作者简介:基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2022.0269
| 组别 | 例数 | 胎龄( | 出生体质量( | 入院出生时间〔M(Q1,Q3),h〕 | SGA〔n( %)〕 | RDS 3~4级〔n( %)〕 | 生后Apgar评分〔M(Q1,Q3),分〕 | ||
|---|---|---|---|---|---|---|---|---|---|
| 1 min | 5 min | 10 min | |||||||
| INSURE组 | 122 | 32(30,33) | 1 505.1±384.8 | 0.5(0.5,1.0) | 55(45.1) | 24(19.7) | 9(7,10) | 10(9,10) | 10(9,10) |
| MV组 | 61 | 30(29,32) | 1 342.4±523.9 | 0.5(0.5,1.0) | 26(42.6) | 10(16.4) | 6(3,9) | 8(6,10) | 9(7,10) |
| 检验统计量值 | -2.926b | 2.152b | -1.463 | 0.100a | 0.289a | -3.888 | -4.575 | -3.913 | |
| P值 | 0.003 | 0.034 | 0.143 | 0.752 | 0.591 | <0.001 | <0.001 | <0.001 | |
| 组别 | 胎位异常〔n(%)〕 | 脐带异常〔n(%)〕 | 胎心异常〔n(%)〕 | 胎盘异常〔n(%)〕 | 羊水污染〔n(%)〕 | 宫内窘迫〔n(%)〕 | 母亲年龄( | 母亲长期居住地海拔高度〔M(Q1,Q3),m〕 | 母亲产检次数〔M(Q1,Q3),次〕 |
| INSURE组 | 8(6.6) | 16(13.1) | 21(17.2) | 17(13.9) | 14(11.5) | 29(23.8) | 29.8±5.8 | 3 903.0(3 651.0,4 300.0) | 5(4,7) |
| MV组 | 6(9.8) | 9(14.8) | 10(16.4) | 5(8.2) | 13(21.3) | 12(19.7) | 30.3±5.6 | 3 800.0(3 651.0,4 150.0) | 5(4,7) |
| 检验统计量值 | 0.619a | 0.093a | 0.019a | 1.266a | 3.128a | 0.393a | 0.517b | -1.525 | -0.131 |
| P值 | 0.432 | 0.761 | 0.889 | 0.261 | 0.077 | 0.531 | 0.606 | 0.127 | 0.896 |
| 组别 | 母亲剖宫产率〔n(%)〕 | 母亲异常分娩率〔n(%)〕 | 母亲为农牧民〔n(%)〕 | 母亲产前糖皮质激素治疗〔n(%)〕 | 母亲不良孕产史〔n(%)〕 | 母亲ICP〔n(%)〕 | 母亲胎膜早破〔n(%)〕 | 母亲妊娠期高血压〔n(%)〕 | 母亲产前感染〔n(%)〕 |
| INSURE组 | 70(57.4) | 9(7.4) | 63(51.6) | 7(5.7) | 42(34.4) | 11(9.1) | 16(13.1) | 63(51.6) | 5(4.1) |
| MV组 | 33(54.1) | 2(3.3) | 37(60.7) | 10(16.4) | 23(37.7) | 7(11.5) | 13(21.3) | 28(45.9) | 2(3.3) |
| 检验统计量值 | 0.178a | 0.592a | 1.334a | 5.480a | 0.191a | 0.277a | 2.049a | 0.536a | 0.074c |
| P值 | 0.673 | 0.441 | 0.248 | 0.019 | 0.662 | 0.598 | 0.152 | 0.464 | 1.000 |
Table 1 Comparison of clinical data of two groups of RDS premature infants
| 组别 | 例数 | 胎龄( | 出生体质量( | 入院出生时间〔M(Q1,Q3),h〕 | SGA〔n( %)〕 | RDS 3~4级〔n( %)〕 | 生后Apgar评分〔M(Q1,Q3),分〕 | ||
|---|---|---|---|---|---|---|---|---|---|
| 1 min | 5 min | 10 min | |||||||
| INSURE组 | 122 | 32(30,33) | 1 505.1±384.8 | 0.5(0.5,1.0) | 55(45.1) | 24(19.7) | 9(7,10) | 10(9,10) | 10(9,10) |
| MV组 | 61 | 30(29,32) | 1 342.4±523.9 | 0.5(0.5,1.0) | 26(42.6) | 10(16.4) | 6(3,9) | 8(6,10) | 9(7,10) |
| 检验统计量值 | -2.926b | 2.152b | -1.463 | 0.100a | 0.289a | -3.888 | -4.575 | -3.913 | |
| P值 | 0.003 | 0.034 | 0.143 | 0.752 | 0.591 | <0.001 | <0.001 | <0.001 | |
| 组别 | 胎位异常〔n(%)〕 | 脐带异常〔n(%)〕 | 胎心异常〔n(%)〕 | 胎盘异常〔n(%)〕 | 羊水污染〔n(%)〕 | 宫内窘迫〔n(%)〕 | 母亲年龄( | 母亲长期居住地海拔高度〔M(Q1,Q3),m〕 | 母亲产检次数〔M(Q1,Q3),次〕 |
| INSURE组 | 8(6.6) | 16(13.1) | 21(17.2) | 17(13.9) | 14(11.5) | 29(23.8) | 29.8±5.8 | 3 903.0(3 651.0,4 300.0) | 5(4,7) |
| MV组 | 6(9.8) | 9(14.8) | 10(16.4) | 5(8.2) | 13(21.3) | 12(19.7) | 30.3±5.6 | 3 800.0(3 651.0,4 150.0) | 5(4,7) |
| 检验统计量值 | 0.619a | 0.093a | 0.019a | 1.266a | 3.128a | 0.393a | 0.517b | -1.525 | -0.131 |
| P值 | 0.432 | 0.761 | 0.889 | 0.261 | 0.077 | 0.531 | 0.606 | 0.127 | 0.896 |
| 组别 | 母亲剖宫产率〔n(%)〕 | 母亲异常分娩率〔n(%)〕 | 母亲为农牧民〔n(%)〕 | 母亲产前糖皮质激素治疗〔n(%)〕 | 母亲不良孕产史〔n(%)〕 | 母亲ICP〔n(%)〕 | 母亲胎膜早破〔n(%)〕 | 母亲妊娠期高血压〔n(%)〕 | 母亲产前感染〔n(%)〕 |
| INSURE组 | 70(57.4) | 9(7.4) | 63(51.6) | 7(5.7) | 42(34.4) | 11(9.1) | 16(13.1) | 63(51.6) | 5(4.1) |
| MV组 | 33(54.1) | 2(3.3) | 37(60.7) | 10(16.4) | 23(37.7) | 7(11.5) | 13(21.3) | 28(45.9) | 2(3.3) |
| 检验统计量值 | 0.178a | 0.592a | 1.334a | 5.480a | 0.191a | 0.277a | 2.049a | 0.536a | 0.074c |
| P值 | 0.673 | 0.441 | 0.248 | 0.019 | 0.662 | 0.598 | 0.152 | 0.464 | 1.000 |
| 组别 | 例数 | 不同胎龄 | ||
|---|---|---|---|---|
| <29周 | 29~32周 | 33~36+6周 | ||
| INSURE组 | 122 | 8(6.6) | 74(60.7) | 40(32.8) |
| MV组 | 61 | 13(21.3) | 35(57.4) | 13(21.3) |
| χ2值 | 9.637 | |||
| P值 | 0.008 | |||
Table 2 Comparison of the composition of premature infants of different gestational ages between two groups
| 组别 | 例数 | 不同胎龄 | ||
|---|---|---|---|---|
| <29周 | 29~32周 | 33~36+6周 | ||
| INSURE组 | 122 | 8(6.6) | 74(60.7) | 40(32.8) |
| MV组 | 61 | 13(21.3) | 35(57.4) | 13(21.3) |
| χ2值 | 9.637 | |||
| P值 | 0.008 | |||
| 组别 | 例数 | 5 min Apgar评分 | ||
|---|---|---|---|---|
| ≤5分 | 6~7分 | 8~10分 | ||
| INSURE组 | 122 | 1(0.8) | 9(7.4) | 112(91.8) |
| MV组 | 61 | 9(3.3) | 10(16.4) | 42(68.9) |
| χ2值 | 18.991 | |||
| P值 | <0.001 | |||
Table 3 Comparison of the composition of premature infants of different 5 min Apgar score between two groups
| 组别 | 例数 | 5 min Apgar评分 | ||
|---|---|---|---|---|
| ≤5分 | 6~7分 | 8~10分 | ||
| INSURE组 | 122 | 1(0.8) | 9(7.4) | 112(91.8) |
| MV组 | 61 | 9(3.3) | 10(16.4) | 42(68.9) |
| χ2值 | 18.991 | |||
| P值 | <0.001 | |||
| 组别 | 例数 | BPD〔n(%)〕 | 肺出血〔n(%)〕 | 气胸〔n(%)〕 | 颅内出血〔n(%)〕 | 第2剂PS〔n(%)〕 | 住院天数〔M(Q1,Q3),d〕 | 死亡〔n(%)〕 |
|---|---|---|---|---|---|---|---|---|
| INSURE组 | 122 | 18(14.8) | 8(6.6) | 6(4.9) | 23(18.9) | 1(0.8) | 27(15,42) | 10(8.2) |
| MV组 | 61 | 16(26.2) | 15(24.6) | 4(6.6) | 7(11.5) | 3(4.9) | 31(4,46) | 24(39.3) |
| χ2(Z)值 | 3.540 | 12.034 | 0.212 | 1.615 | 3.195 | -0.157a | 26.081 | |
| P值 | 0.060 | 0.001 | 0.733 | 0.289 | 0.109 | 0.875 | <0.001 |
Table 4 Comparison of complications and outcomes between two groups of RDS premature infants
| 组别 | 例数 | BPD〔n(%)〕 | 肺出血〔n(%)〕 | 气胸〔n(%)〕 | 颅内出血〔n(%)〕 | 第2剂PS〔n(%)〕 | 住院天数〔M(Q1,Q3),d〕 | 死亡〔n(%)〕 |
|---|---|---|---|---|---|---|---|---|
| INSURE组 | 122 | 18(14.8) | 8(6.6) | 6(4.9) | 23(18.9) | 1(0.8) | 27(15,42) | 10(8.2) |
| MV组 | 61 | 16(26.2) | 15(24.6) | 4(6.6) | 7(11.5) | 3(4.9) | 31(4,46) | 24(39.3) |
| χ2(Z)值 | 3.540 | 12.034 | 0.212 | 1.615 | 3.195 | -0.157a | 26.081 | |
| P值 | 0.060 | 0.001 | 0.733 | 0.289 | 0.109 | 0.875 | <0.001 |
| 因素 | B | Wald χ2值 | OR值 | 95%CI | P值 |
|---|---|---|---|---|---|
| 胎龄 | 0.253 | 4.211 | 1.288 | (1.011,1.641) | 0.040 |
| 出生体质量 | -0.001 | 0.001 | 0.999 | (0.998,1.001) | 0.315 |
| 生后1 min Apgar评分 | 0.019 | 0.028 | 1.019 | (0.815,1.275) | 0.867 |
| 生后5 min Apgar评分 | 0.771 | 8.579 | 2.162 | (1.291,3.622) | 0.003 |
| 生后10 min Apgar评分 | -0.330 | 1.519 | 0.719 | (0.426,1.215) | 0.218 |
| 母亲产前糖皮质激素治疗 | 1.869 | 9.682 | 6.482 | (1.997,21.039) | 0.002 |
Table 5 Multivariate Logistic regression analysis of influencing factors of different NRDS treatment schemes for premature infants
| 因素 | B | Wald χ2值 | OR值 | 95%CI | P值 |
|---|---|---|---|---|---|
| 胎龄 | 0.253 | 4.211 | 1.288 | (1.011,1.641) | 0.040 |
| 出生体质量 | -0.001 | 0.001 | 0.999 | (0.998,1.001) | 0.315 |
| 生后1 min Apgar评分 | 0.019 | 0.028 | 1.019 | (0.815,1.275) | 0.867 |
| 生后5 min Apgar评分 | 0.771 | 8.579 | 2.162 | (1.291,3.622) | 0.003 |
| 生后10 min Apgar评分 | -0.330 | 1.519 | 0.719 | (0.426,1.215) | 0.218 |
| 母亲产前糖皮质激素治疗 | 1.869 | 9.682 | 6.482 | (1.997,21.039) | 0.002 |
| [1] |
|
| [2] |
邵肖梅,叶鸿瑁,丘小汕. 实用新生儿学[M]. 第5版. 北京:人民卫生出版社,2019.
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
赵捷,杨传忠. 超早产儿发生支气管肺发育不良的影响因素[J]. 中华围产医学杂志,2017,20(11):824-828. DOI:10.3760/cma.j.issn.1007-9408.2017.11.012.
|
| [10] |
李帅军,冯琪,童笑梅,等. 超低出生体质量儿复苏及呼吸支持治疗的多中心临床研究[J]. 中华新生儿科杂志,2021,36(2):27-32. DOI:10.3760/cma.j.issn.2096-2932.2021.02.005.
|
| [11] |
|
| [12] |
|
| [13] |
超未成熟儿与超低出生体质量儿研究协作组. 超未成熟儿与超低出生体质量儿产前糖皮质激素使用情况及其对预后影响的多中心调查[J]. 中华围产医学杂志,2020,23(5):302-310. DOI:10.3760/cma.j.cn113903-20190823-00512.
|
| [14] |
江苏省NICU母乳喂养质量改进临床研究协作组. 江苏省13家医院极早产儿死亡危险因素分析[J]. 中华新生儿科杂志,2021,36(5):24-29. DOI:10.3760/cma.j.issn.2096-2932.2021.05.006.
|
| [15] |
德穷,吴俣,张育彤,等. 西藏藏族孕产妇产前检查次数与低出生体质量儿的关联[J]. 中华疾病控制杂志,2019,23(11):1348-1352. DOI:10.16462/j.cnki.zhjbkz.2019.11.010.
|
| [16] |
李才萍. 妊娠期高血压疾病患者终止妊娠时机及分娩方式临床研究[J]. 实用妇科内分泌电子杂志,2017,4(23):64-65. DOI:10.3969/j.issn.2095-8803.2017.23.043.
|
| [17] |
|
| [18] |
超未成熟儿与超低出生体质量儿研究协作组. 超未成熟儿与超低出生体质量儿临床救治结局分析[J]. 中华新生儿科杂志,2020,35(2):108-112. DOI:10.3760/cma.j.issn.2096-2932.2020.02.008.
|
| [19] |
李天浩,林新祝. 早期呼吸支持技术对早产儿神经系统预后的影响[J]. 中华新生儿科杂志,2018,33(5):392-396. DOI:10.3760/cma.j.issn.2096-2932.2018.05.020.
|
| [20] |
江苏省新生儿重症监护病房母乳质量改进临床研究协作组. 多中心回顾性分析极低及超低出生体质量儿支气管肺发育不良的临床特点及高危因素[J]. 中华儿科杂志,2019,57(1):33-39. DOI:10.3760/cma.j.issn.0578-1310.2019.01.009.
|
| [21] |
董梦园,吉玲,刘萌萌,等. 呼吸窘迫综合征早产儿发生支气管肺发育不良的危险因素分析[J]. 中国儿童保健杂志,2021,29(6):685-688. DOI:10.11852/zgetbjzz2020-2150.
|
| [22] |
庄严,高喜容,刘新晖,等. 超早产儿出院时临床结局及影响因素分析[J]. 中华新生儿科杂志,2017,32(2):86-90. DOI:10.3760/cma.j.issn.2096-2932.2017.02.003.
|
| [1] | LI Jiawei, GAO Xinyi, GE Aoqi, LI Juanjuan, YUAN Beibei. Demand and Associated Factors for Integrated Medical Care and Preventive Services among Patients with Type 2 Diabetes [J]. Chinese General Practice, 2026, 29(21): 3028-3039. |
| [2] | HAN Congcong, QIU Xinyu, SHAN Chunfang, SONG Ning, CHEN Qingjie, MULADILI· Abudureheman, LI Xiaomei, YANG Yining, ZHAO Qian. Impact of Metabolic Obesity Phenotype on Long-term Prognosis after Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome [J]. Chinese General Practice, 2026, 29(21): 2950-2958. |
| [3] | LI Feng, HU Changhao, LUO Xu. Progress in the Study of Influencing Factors and Intervention Strategies of Mental Health in Elderly Patients with Multiple Chronic Conditions [J]. Chinese General Practice, 2026, 29(20): 2816-2828. |
| [4] | ZHANG Huifang, CHEN Cunchuan, FAN Boyang, SUN Wenning, WANG Yingjie, ZHANG Ao, ZHAO Yang, WANG Haipeng. Study on the Service Capability of Primary Care Doctors to Integrate Medical and Preventive Services and Its Influencing Factors in Shandong Province [J]. Chinese General Practice, 2026, 29(19): 2711-2716. |
| [5] | TANG Lijuan, QI Qi, ZHANG Fan, GAO Yifu, CAO Yajing, YUE Fujuan, GAO Jinchai, LIU Xiaoli. Characterisation of the Prevalence of Overweight/Obesity among Residents Aged 18-44 Years in Hebei Province in 2013 and 2020 [J]. Chinese General Practice, 2026, 29(19): 2695-2704. |
| [6] | LIU Yang, ZHOU Guoping, LI Xiaoshi, LI Ping, ZHANG Xin. Impact of Acute Respiratory Distress Syndrome Etiology on the Prognostic Value of Driving Pressure: a Prospective Cohort Study [J]. Chinese General Practice, 2026, 29(19): 2638-2647. |
| [7] | LIU Fang, LIU Weinan, XIANG Yuanyue, LU Cheng, ZHU Binhai. Factors Influencing Work-related Flow among "3+2" Order-oriented Assistant General Practitioners in Jiangsu Province [J]. Chinese General Practice, 2026, 29(18): 2454-2460. |
| [8] | LUAN Xiaoqing, SUN Jingjing, LI Xiaoling, WANG Manxia. Research Progress on Potential Biomarkers of Neuromyelitis Optica Spectrum Disorder [J]. Chinese General Practice, 2026, 29(17): 2418-2424. |
| [9] | CHEN Yan, SHEN Dequan, SHENG Renlei, CHANG Yujie, YANG Jiaqi, DING Jie, SUN Zhifang, WANG Dahui. Influencing Factors and Importance Ranking of the Utilization of Primary-level Traditional Chinese Medicine Preventive and Health Care Services for the Elderly [J]. Chinese General Practice, 2026, 29(16): 2182-2189. |
| [10] | YU Shan, CHE Yajie, SUBIYINUER· Maimaiti, GUO Kaiyang, FENG Xingxing, YAN Ping. A Comparative Study on the Current Situation and Influencing Factors of Subjective Cognitive Decline among Urban and Rural Elderly People in Xinjiang [J]. Chinese General Practice, 2026, 29(16): 2227-2233. |
| [11] | CHEN Bihua, LIN Qiyi, LI Wuhua, SU Jin, TU Liping, SHI Lan, DING Xiaoqin, YI Chuntao. The Influencing Factors and Mechanisms of the Work Output Level of Family Doctor Teams from the Perspective of Team Effectiveness [J]. Chinese General Practice, 2026, 29(16): 2167-2173. |
| [12] | YU Chao, SONG Lihua, WANG Linyan, LU Yunping, WANG Linyang, CUI Wei. The Functional Outcomes and Influencing Factors in Patients with First-episode Major Depressive Disorder after 7 Years [J]. Chinese General Practice, 2026, 29(16): 2221-2226. |
| [13] | LUO Yutong, LI Jing. The HPV Vaccine Coverage and Its Influencing Factors among the Eligible Population in China Based on a Geographically Weighted Regression Model [J]. Chinese General Practice, 2026, 29(16): 2234-2243. |
| [14] | FU Mingyuan, YU Xiaoyi, GE Caiying, KONG Min. Impaired Awareness of Hypoglycemia: Prevalence and Determinants among Community-based Patients with Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2026, 29(16): 2252-2258. |
| [15] | ZHAO Xuedan, AI Yue, JIN Guoen, JIA Guoqiang. The New Research Progress of Non-infectious Lung Diseases in High Altitude Areas [J]. Chinese General Practice, 2026, 29(14): 1931-1938. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||